This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galdiero, M.
Right arrow Articles by Tortora, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galdiero, M.
Right arrow Articles by Tortora, A.

 Previous Article  |  Next Article 

Infection and Immunity, January 2001, p. 221-227, Vol. 69, No. 1
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.1.221-227.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Haemophilus influenzae Porin Contributes to Signaling of the Inflammatory Cascade in Rat Brain

Massimiliano Galdiero,1 Michele D'Amico,2 Fernanda Gorga,3 Clara Di Filippo,2 Marina D'Isanto,3 Mariateresa Vitiello,3,* Anna Longanella,3 and Annalisa Tortora3

Dipartimento di Patologia e Sanità Animale, Facoltà di Veterinaria, Università degli Studi di Napoli Federico I, 80137 Naples,1 and Istituto di Farmacologia e Tossicologia2 and Istituto di Microbiologia,3 Facoltà di Medicina e Chirurgia, Seconda Università degli Studi di Napoli, 80138 Naples, Italy

Received 17 July 2000/Returned for modification 1 September 2000/Accepted 6 October 2000


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In the present study we observed that the Haemophilus influenzae type b (Hib) porin, among the different surface bacterial components, is involved in the pathophysiology of bacterial meningitis. This study demonstrates that inoculation of Hib porin into the fourth cerebral ventricle causes the simultaneous expression of interleukin-1alpha (IL-1alpha ), tumor necrosis factor alpha (TNF-alpha ), and macrophage inflammatory protein 2 (MIP-2) at 6 h after inoculation. At 24 h, the expression of MIP-2 decreases while the expression of IL-1alpha and TNF-alpha increases. The mRNA expression of IL-1alpha , TNF-alpha , and MIP-2 is correlated with injury to the blood-brain barrier as demonstrated by the appearance of serum proteins and leukocytes in cerebrospinal fluid and by the increase in brain water content.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Most diseases caused by Haemophilus influenzae type b (Hib) occur in young children (under the age of 5 years). This microorganism is a common cause of meningitis. The advent of vaccination programs has almost eradicated the disease from wealthy countries, but the infection is still present in less developed areas (1, 27, 30).

An understanding of the pathophysiology of bacterially induced brain injury is essential in identifying mediators which may be important in this process. It is generally accepted that the inflammatory response to gram-negative bacteria infection is induced by endotoxin. Hib lipopolysaccharide (LPS) plays a fundamental role in rats meningeal inflammation (39, 47). Although LPS has been clearly documented to play an important role in the pathogenesis of gram-negative infections (53), very little is known about the functions of other bacterial components. In fact, there is significant evidence that other components of gram-negative bacteria also play an important role in the pathology associated with these infections (12, 25, 46).

Hib porin (also known as P2 or protein BLC) is the most dominant band in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of outer membrane protein preparations (31, 35, 37); its molecular mass varies between 36 and 42 kDa (37). This protein exists as a trimer and functions as a porin (8). Hib porin has also been reported to be an important immunoprotection target (23).

Tumor necrosis factor alpha (TNF-alpha ) and interleukin-1 (IL-1) play important roles in the host response to bacteria and their products. Astrocytes and microglial cells produce IL-1 and TNF-alpha within the central nervous system (CNS) (13, 15). The evolution of the inflammatory process in the CNS depends on the set of cytokines released during the first steps of the infection. Noxious stimuli that act directly on neuronal soma are highly effective in generating chemokine expression. IL-1 is a polypeptide that acts as a soluble mediator in immunological and inflammatory reactions. Woolpe et al. (52) characterized a novel cytokine termed macrophage inflammatory protein 2 (MIP-2) that exhibits a strong affinity for heparin. MIP-2 is secreted by endotoxin-stimulated macrophages. Sequence analysis indicates that MIP-2 is a member of the platelet factor 4 family. This mediator is an extremely potent chemotactic agent for human neutrophils but induces little chemokinetic activity in vitro (10, 48).

Within the first 24 h after a mechanical trauma to the CNS, reactive astrogliosis develops and injury sites are infiltrated by mononuclear phagocytes derived from blood-borne monocytes and endogenous microglia (2, 3). The chemokine expression in posttraumatic inflammation is generally restricted to the monocyte chemoattractant MCP-1 (44) and occurs before hematogenous cells penetrate neuronal tissues.

It is still unclear how leukocytes migrate through the blood-brain barrier. Two types of mechanisms are involved during the migration of blood cells across the tight endothelial cell barrier of the brain vessels: (i) cellular adhesion molecules of endothelial cells and their counterreceptors on leukocytes induce the attachment of circulating blood cells to the vessel wall, and (ii) chemokines activate and attract specific leukocyte subpopulations, leading to translocation and accumulation of these cells in the inflamed tissue. Among the other components of the surface of gram-negative organisms, the porins activate the adhesion molecules (11), induce leukocyte transmigration through human endothelial cells in vitro (22), and stimulate cytokine liberation (17, 20, 21, 26).

Furthermore, to establish the exact pathogenic mechanisms by which Hib contributes to signaling of the inflammatory cascade, it is important to characterize the pattern of cytokine release after stimulation with Hib cellular components.

In this work we investigate the potential role of Hib porin in the pathophysiology of bacterial brain inflammation.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Bacteria and growth conditions. Hib was obtained from the American Type Culture Collection (ATCC 9795) and grown in CY medium (9) for 18 to 24 h at 37°C; the cells were harvested at the end of the exponential growth phase.

Animals. Male Sprague-Dawley rats (250 to 300 g each) with free access to food and water were housed at constant temperature (21 ± 1°C) and relative humidity (60%). The animals were maintained under a regular 12-h light/12-h dark schedule (light from 7.00 a.m. to 7.00 p.m.).

Surgical preparation and treatment. The rats were placed in a stereotaxic apparatus (David Kopf Instruments, Tujunga, Calif.) under ketamine anesthesia (100 mg/kg intraperitoneally), and a craniotomy was performed by following the coordinates of the atlas of Paxinos and Watson (42) (measured in millimeters from the bregma; AP.-11.60; L. 2.3; V. 7.5) to permit microinjection into the fourth ventricle (4 V). The intracerebroventricular microinjections (time zero) were conducted with a Hamilton 10-µl syringe attached to the stereotaxic micromanipulator and inserted into the cerebral tissue. A volume of 7 µl was used either for control injections (0.2 M phosphate-buffered saline) (PBS) (pH 6.5) as well as for injection of drugs, over a period of 10 s. After this procedure the rats were allowed to recover until the brain was removed for in vitro assays.

After the completion of the experiment, at each time point considered the rats were killed with a high dose of pentobarbital (200 mg/kg intravenously) and the brains were removed. They were immersed into D solution (4 M guanidine thiocyanate, 25 mM sodium citrate [pH 7.0], 0.5% sarcosyl, 0.1 M beta -mercaptoethanol) for RNA extraction.

A separate series of experiments were performed to verify the injection site. The rats subjected to the above surgical procedure were injected intracerebroventricularly 10 µl of 5 mM (0.2%) methylene blue solution before being sacrificed with a high dose of pentobarbital (200 mg/kg intravenously). The animals were immediately perfused intracardially with 50 ml of PBS followed by 50 ml of a 10% formalin solution in PBS. The brains were removed and immersed in saturated formalin for 24 h. The injection site was verified using two consecutive sections (40 µm), one stained with cresyl violet to identify the nuclei and the other unstained to determine the diffusion of the dye.

Preparation of the porin. The porin was isolated and purified from cells of Hib ATCC 9795 using the modified method of Nurminen (41). Briefly, the bacterial envelopes were treated with Triton X-100 buffer for 2 h at 37°C with rotary shaking, dissolved in SDS buffer (4% [wt/vol] SDS, 0.1 M sodium phosphate [pH 7.2]), and applied to an Ultragel ACA34 column equilibrated with 0.25% SDS-sodium azide buffer. Elution flow through the column was 8 ml h-1, and 2 ml was collected. The fraction containing proteins, identified by measuring the absorption at 280 nm, was extensively dialyzed and checked by SDS-PAGE by the method of Laemmli (28). The protein content of the porin preparation was determined by the method of Lowry et al. (32). All possible traces of LPS were revealed on SDS-PAGE gels stained with silver nitrate as described by Tsai and Frasch (50) and by the Limulus amoebocyte lysate assay as described by Thye Yin et al. (49).

The pore-forming ability of our preparation was checked by a functional assay (liposome-swelling assay) after incorporation into proteoliposomes by the method of Nikaido and Rosenberg (40).

Preparation of Hib LPS. Hib LPS was extracted by the phenol-chloroform-petroleum ether method of Galanos et al. (16).

N-terminal sequencing of Hib porin. The Applied Biosystems model 477A automatic protein sequencer has been used to determine the N-terminal sequence of the Hib porin. The phenylthiohydantoin (PTH)-aa released during the degradation have been identified by high-performance liquid chromatography on a model 120A high-performance liquid chromatograph (Applied Biosystem) with a Brownlee C18 column. Separation was performed with an eluent gradient as suggested by the manufacturer. The column was set at 54°C, and the elution was monitored by measuring the absorbance at 269 nm. Data were elaborated by a computer Macintosh Ilsi.

Inocula. Highly purified porin (5 µg in 7 µl) from Hib outer membranes were used. In some assays the LPS activity in the porins was neutralized by adding polymyxin B (PB) at room temperature for 1 h (4, 34). The porin-PB mixture was used in pyrogen-free PBS. The controls were inoculated with bovine serum albumin (5 µg in 7 µl) or PBS (7 µl) or porin-PB mixture (5 µg in 7 µl plus 5 ng) or PB (1 µg in 7 µl) or LPS (1 µg in 7 µl) or LPS-PB mixture (1 µg in 7 µl plus 1 µg).

Determination of the water and protein contents in the brain. At 6 and 24 h after postintracerebroventricular inoculation, the rats were killed by an overdose of pentobarbital given intravenously. Immediately after death, a craniotomy was performed; the brain without the cerebellum and medulla was removed, weighed in aluminium boats, and dried in a stove for 16 h at 130°C to a stable weight. The brain water content, expressed as grams of water per 100 g of dry weight, was determined by using the formula [(wet weight - dry weight)/wet weight] × 100 and used as an estimation of brain edema. The cerebrospinal fluid (CSF) samples were centrifuged at 10,000 × g for 5 min and the supernatant fluid was assayed to establish the protein content by the Bradford method (5).

CSF pleocytosis and histologic assays. The CSF was collected from rats by intra-4 V puncture at 6 and 24 h after inoculation. Leukocyte concentrations were measured with a hemocytometer and by microscopic evaluation after May-Grunwald coloration. Histologic assays were performed on transverse sections.

RNA isolation and cDNA preparation. The brain samples were collected 6 and 24 h after stimulation, and total RNA was extracted by the method of Chomczynski and Sacchi (7). The RNA pellet was resuspended in 75% (vol/vol) ethanol, sedimented, vacuum dried, and dissolved in 15 µl of RNase-free water. 1 µg of oligo(dT) (Promega, Madison, Wis.) was added to the suspension, and the mixture was heated at 65°C for 5 min. After cooling on ice, the mixture was incubated for 2 h at 42°C with 14 µl of the following solution: 20 mM dithiothreitol (Sigma), 1 mM (each) dATP, dGTP, dCTP, and dTTP, 35 U of RNasin (Promega), and 525 U of Moloney murine leukemia virus reverse transcriptase (Promega) in reverse transcription buffer.

PCR procedure. Murine cytokine primer pairs sequences were designed on the basis of published gene sequences as reported in Table 1. The primer sequences were complementary to sequences in the exons or spanned exon-exon junctions and thus were RNA specific. A 2-µl volume of cDNA prepared as described above was amplified in the presence of 500 nM (final concentration) 5' and 3' primers, 200 µM (each) dATP, dGTP, dCTP, dTTP, and 1.25 U of Taq DNA polymerase (Promega) in a final volume of 50 µl of 10× Taq DNA polymerase buffer (Promega). The PCR was performed in a Perkin-Elmer thermal cycler for 30 cycles of 1 min of denaturation at 94°C, 2 min of annealing at 60°C, and 3 min of extension at 72°C. The reaction product was visualized by electrophoresis using 25 µl of the reaction mixture at 100 V in a 1.5% agarose gel containing ethidium bromide (1 µg/ml). The gels were then examined on an UV light box and photographed. BglI- and HinfI-digested pBR328 DNA (Boehringer Mannheim) (1 µg) was run in parallel as a molecular size marker (providing bands at 2,176, 1,766, 1,230, 1,033, 653, 517, 453, 394, 298, 234, 220, and 154 bp).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Primer sequences used for PCR-assisted mRNA amplification

Statistics. All experiments were carried out in triplicate; the results are expressed as the mean ± standard error. Comparisons between tests were done by Student's t test, with statistical significance considered to be indicated by P < 0.05.


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Purity of Hib porin preparations. The purity of the porin preparation from Hib, as checked by SDS-PAGE, is shown in Fig. 1. SDS-PAGE revealed one band with a molecular mass of approximately 40 kDa, as previously reported by Coulton et al. (8). In the same gel, we found a Hib outer membrane preparation (Fig. 1, lane C), demonstrating that the 40-kDa band is the most dominant in the bacterial strain used. This protein showed porin activity as demonstrated by its ability to form transmembrane aqueous channels (data not shown). Moreover, the N-terminal sequence (Ala-Val-Val-Tyr-Asn-Asn-Glu-Gly-Thr-Asn-Val) of the isolated protein corresponds to the known sequence for the protein as reported in literature (24, 36). The purification and contamination by LPS in the preparations obtained have been amply addressed in previous works (18, 20). Using the Limulus test, the LPS contamination in the porin preparation was estimated to be about 0.001% (wt/wt) compared with a standard Hib LPS solution.


View larger version (63K):
[in this window]
[in a new window]
 
FIG. 1.   SDS-PAGE analysis of the outer membrane protein preparation and porin extract from Hib ATCC 9795. The gel was stained with Coomassie blue. Lanes: A, molecular mass standards (phosphorylase b, 94 kDa; albumin, 67 kDa; ovalbumin, 43 kDa; carbonic anydrase, 30 kDa; trypsin inhibitor, 20 kDa; alpha -lactalbumin, 14 kDa); B, Hib porin (10 µg); C, Hib OMP preparation (10 µg).

Water and protein contents in the brain. Intracerebral inoculation of rats with Hib porin was performed with a dose of 5 µg, which is able to achieve a porin concentration in CSF approximately within the range of those that elicited a biological effect in vitro (19, 21, 22). The water content in the brain was significantly elevated in rats inoculated intracerebrally with porin compared to rats inoculated with PBS, BSA, LPS-PB, or PB alone. The results of the edema evaluation are reported in Table 2. The porin caused also an increase in protein concentration in CSF; 24 h after inoculation, the protein content was notably increased compared to the controls (Table 2).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   Ability of Hib porin to provoke meningeal inflammation after 24 h of treatmenta

CSF pleocytosis and histologic examinations. Intra-4 V inoculation of Hib porin elicited a discrete pleocytosis compared to controls. Inoculation of 5 µg of Hib porin at 24 h increased the leukocyte concentration in CSF (mean, 378 ± 130/µl) (P < 0.001) much more than that found when using PBS or other controls (mean, 40 ± 5/µl). Also, Hib LPS (1 µg) at 24 h increased the leukocyte concentration in CSF (mean, 350 ± 120/µl) (P < 0.001). No significant differences were observed with respect to controls after 6 h. The results are reported in Table 2. Histologic assays of the transverse brain sections obtained 24 h after the treatment with porin showed a small infiltration of polymorphonuclear cells that was higher than that in controls (data not shown).

Cytokine mRNA expression in the brain. An analysis of cytokine mRNA in brain tissues from rats intracerebroventricularly inoculated with Hib porin and different controls was performed using reverse transcription-PCR (RT-PCR) and focused on tissues obtained from rats at 6 and 24 h after treatment. At our limits of detection, mRNAs for gamma interferon (IFN-gamma ), IL-6, IL-4, and IL-10 were not expressed in brain tissues from untreated rats. TNF-alpha and MIP-2 mRNA bands were weak in controls inoculated intracerebroventricularly with PBS, PB, LPS-PB, or BSA at 6 and 24 h, whereas IL-1alpha mRNA was detected in controls only after 24 h. The patterns of cytokine mRNA expression at 6 h postinoculation in brains from rats inoculated intra-4 V with Hib porin or LPS as a positive control are shown in Fig. 2A, while the equivalent results 24 h postinfection are shown in Fig. 3A. The results obtained were confirmed by quantitation of mRNA using Sigma Gel software (Fig. 2B and Fig. 3B); the percentages of integrated peak areas are reported in Table 3. As detected by RT-PCR analysis, cytokine mRNA bands were present for IL-1alpha , TNF-alpha , and MIP-2 at 6 and 24 h after treatment. No effect was detected for IFN-gamma , IL-6, IL-4, and IL-10 mRNA under the same experimental conditions. TNF-alpha and IL-1alpha mRNA were found only after 6 h, and their levels increased after 24 h; in contrast, MIP-2 mRNA was found at 6 h and its level decreased at 24 h. The MIP-2 band intensity at 6 h after treatment with porin was higher than the TNF-alpha and IL-1alpha band intensities obtained at 24 h. As a control, we measured the levels of beta -actin mRNA, which is a cell cycle-independent mRNA. The actin mRNA levels remained unchanged, indicating that the changes in cytokine mRNA levels were not caused by a general increase in all poly(A)+ RNA species. Similar results were obtained in independent experiments with brains from different rats.


View larger version (54K):
[in this window]
[in a new window]
 
FIG. 2.   A representative experiment (IL-1alpha , TNF-alpha , IL-6, IFN-gamma , IL-4, IL-10, and MIP-2) showing mRNA expression in rat brain 6 h after Hib porin inoculation. (A) The brain samples were collected after stimulation with PBS (7 µl), LPS Hib (1 µg), LPS Hib plus PB (1 µg + 1 µg), Hib porin (5 µg), Hib porin plus PB (5 µg + 5 ng), PB (1 µg), or BSA (5 µg) and then subjected to RNA extraction and RT-PCR amplification. Reaction products were run on a 1.5% agarose gel in the presence of appropriate molecular mass markers; beta -actin was the positive transcription control. (B) RT-PCR quantitation of the cytokine results by Sigma Gel software.


View larger version (50K):
[in this window]
[in a new window]
 
FIG. 3.   A representative experiment (IL-1alpha , TNF-alpha , IL-6, IFN-gamma , IL-4, IL-10, and MIP-2) showing mRNA expression in rat brain 24 h after Hib porin inoculation. (A) The brain samples were collected after stimulation with PBS (7 µl), LPS Hib (1 µg), LPS Hib plus PB (1 µg + 1 µg), Hib porin (5 µg), Hib porin plus PB (5 µg + 5 ng), PB (1 µg), or BSA (5 µg) and then subjected to RNA extraction and RT-PCR amplification. Reaction products were run on a 1.5% agarose gel in the presence of appropriate molecular mass markers; beta -actin was the positive transcription control. (B) RT-PCR quantitation of cytokine results by Sigma Gel software.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 3.   Quantitation (by Sigma Gel software) of cytokine mRNA signals at 6 and 24 h after treatment


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Our results show that the Hib porin induces the early release of cytokines by CNS cells, amplifying the inflammatory response. The Hib porin, inoculated at 5 µg into the fourth ventricle of the brain, elicited the appearance of serum proteins in CSF and the development of brain edema, as demonstrated by an increase in the water content in the brain. These modifications were followed by a small increase in the number of neutrophils both in CSF and in the tissue sections around the inoculation site. IL-1alpha , TNF-alpha , and MIP-2 mRNA appeared quickly in the tissue near the inoculation site. No information concerning the possible role of porins in inducing the symptoms of bacterial meningitis has been published to date. It can be ruled out that the effects shown by Hib porin are attributable to contaminating traces of LPS, because the same results were obtained using Hib porin plus PB whereas LPS plus PB did not show any activity. The concentration of porins used contains a biologically inactive percentage of LPS (0.001%, wt/wt), which is unable to elicit the results obtained under our experimental conditions. An active concentration of both LPS and porin can frequently be reached at infection sites from outer membrane blebbing or bacterial lysis of gram-negative bacteria as a consequence of host defenses (53). Considering that the level of porins is about 105 molecules/cell and that of LPS is about 3.4 × 106 molecules/cell (6), 108 bacterial cells are enough to reach concentrations of about 5 µg of porins per ml (about 0.2 µM) and 1 µg of LPS per ml (about 0.5 µM).

Furthermore, the effects observed were not caused by the mechanical trauma following the intracerebral inoculation of extraneous substances; indeed, PBS, PBS plus PB, or PBS plus BSA did not show the same intensity of the signal from IL-1alpha and TNF-alpha mRNA. Moreover, the alterations in the parameters of the blood-brain barrier are significantly different in the rats treated with the Hib porin compared to controls. Within the first 24 h after mechanical trauma to the CNS, it was possible to observe increased levels of MCP-1 mRNA; astrocytes are the cellular source of MCP-1 mRNA at early times after mechanical brain injury (44). This is in accordance with previous studies showing that TNF-alpha and IL-1 have been detected in the CSF of patients with bacterial meningitis caused by gram-positive and gram-negative microorganisms (29, 33) and in the CSF of animals experimentally inoculated with Hib (38), Hib LPS (B. Wispelwey, W. J. Long, J. M. Castracane, and W. M. Scheld, Program Abstr. 28th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 873, 1988), Neisseria meningitidis (51) and pneumococcal cell wall fragment (I. Riesenfeld-Orn, J. Garcìa-Bustos, M. Hoffman, and E. Tuomanen, Program Abstr. 28th Intersci. Conf. Antimicrob. Agents Chemother., abstr. 876, 1988). TNF-alpha and IL-1, produced from astrocytes and microglial cells in the early stages of the inflammatory process, play an important role in the host response to bacteria and their products (43). Indeed, monoclonal antibody to TNF-alpha reduced inflammation and was also protective against brain edema in a rabbit model of pneumococcal meningitis (45). Furthermore, injection of meningococcal LPS into the subarachnoid space of rabbits induced the subsequent appearance of TNF-alpha , IL-1, and IL-6 followed by the migration of leukocytes into the CSF compartment (51). Therefore, our results show that the Hib porin also initially induces the synthesis of TNF-alpha and IL-1alpha mRNA followed by brain edema and a slight neutrophil infiltration. In our experiments, we did not observe the expression of IL-6 mRNA by astrocytes and microglial cells. Its expression probably occurs later than that of other cytokines; in fact it was demonstrated that IL-6 mRNA appears in CNS viral infection only after 48 h (14).

Hib porin, even at an early stage, induces the appearance of leukocytes in CSF. For this reason, we looked for the presence of any chemotactic cytokines. MIP-2 is a chemoattractant (10) and an activating factor for neutrophils (48). MIP-2 is made by cytokine- or LPS-activated monocytes and also by endothelial cells. The release of MIP-2 into the tissue of the CNS may be caused by both in situ and infiltrated cells.

We could not observe any expression of IFN-gamma , IL-4, and IL-10 mRNA in the CNS tissue at the times of incubation we used, probably because the lymphocyte infiltration happens later.

In conclusion, the interplay between bacterial components and host inflammatory cells is likely to be a major determinant of the experimental presentation and outcome of bacterial brain edema. The further study of regulation and coordination of chemokine release and production by bacterial components in brain tissue may lead to novel therapeutic approaches to bacterially induced brain inflammation.


    FOOTNOTES

* Corresponding author. Mailing address: Istituto di Microbiologia, Facoltà di Medicina e Chirurgia, Seconda Università degli Studi di Napoli, Larghetto S. Aniello a Caponapoli no. 2, 80138 Naples, Italy. Phone: 39-081-5665662. Fax: 39-081-5665663. E-mail: francesco.galdiero{at}unina2.it.

Editor:   D. L. Burns


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Adegbola, R. A., S. O. Usen, M. Weber, N. Lloyd-Evans, K. Jobe, K. Mulholland, K. P. W. J. McAdam, B. M. Greenwood, and P. J. M. Milligan. 1999. Haemophilus influenzae type b meningitis in the Gambia after introduction of a conjugate vaccine. Lancet 354:1091-1092[CrossRef][Medline].
2. Balasingam, V., K. Dickson, A. Brade, and V. W. Yong. 1996. Astrocyte reactivity in neonatal mice: apparent dependence on the presence of reactive microglia/macrophages. Glia 18:11-26[CrossRef][Medline].
3. Balasingam, V., T. Tejada-Berges, E. Wright, R. Bouckova, and V. W. Yong. 1994. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J. Neurosci. 14:846-856[Abstract].
4. Blanchard, D. K., J. Y. Djeun, T. W. Klein, H. Friedman, and W. E. Stewart. 1986. Interferon-gamma induction by lipopolysaccharide: dependence on interleukin 2 and macrophages. J. Immunol. 136:963-970[Abstract].
5. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 72:248-254[CrossRef][Medline].
6. Brass, J. M. 1986. The cell envelope of Gram-negative bacteria: new aspect of its function in transport and chemotaxis. Curr. Top. Microbiol. Immunol. 29:1-8.
7. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenoi-chloroform extraction. Anal. Biochem. 162:156-159[Medline].
8. Coulton, J. W., A. C. Chin, and V. Vachon. 1992. Recombinant porin of Haemophilus influenzae type b. J. Infect. Dis. 165(Suppl. 1):S188-S191.
9. Coulton, J. W., and I. F. Wan. 1983. The outer membrane of Haemophilus influenzae type b: cell envelope associations of major proteins. Can. J. Microbiol. 29:280-287[Medline].
10. Diab, A., H. Abdalla, H. L. Li, F. D. Shi, J. Zhu, B. Hojberg, L. Lindquist, B. Wretlind, M. Bakhiet, and H. Link. 1999. Neutralization of macrophage inflammatory protein 2 (MIP-2) and MIP-1 alpha  attenuate neutrophils recruitment in the central nervous system during experimental bacterial meningitis. Infect. Immun. 67:2590-2601[Abstract/Free Full Text].
11. Donnarumma, G., F. Brancaccio, G. Cipollaro de l'Ero, A. Folgore, A. Marcatili, and M. Galdiero. 1996. Release of GM-CSF, sELAM-1 and sICAM-1 by human vascular endothelium stimulated with Gram-negative and Gram-positive components. Endothelium 4:11-22.
12. Evans, T. J., E. Strivens, A. Carpenter, and J. Cohen. 1993. Differences in cytokine response and induction of nitric oxide synthase in endotoxin-resistant and endotoxin-sensitive mice after intravenous Gram-negative infection. J. Immunol. 150:5033-5040[Abstract].
13. Fontana, A., H. Hengartner, N. de Tribolet, and E. Weber. 1984. Glioblastoma cells release interleukin-1 and factors inhibiting interleukin-2 mediated effects. J. Immunol. 132:1837-1844[Abstract].
14. Frei, K., U. V. Malipiero, T. P. Leist, R. M. Zinkernagel, M. E. Schwab, and A. Fontana. 1989. On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. Eur. J. Immunol. 19:689-694[Medline].
15. Frei, K., C. Siepl, P. Groscurth, S. Bodmer, C. Schwerdel, and A. Fontana. 1987. Antigen presentation and tumor cytotoxicity by interferon-gamma -treated microglial cells. Eur. J. Immunol. 17:1271-1278[Medline].
16. Galanos, C., O. Luderitz, and O. Westphal. 1969. A new method for the extraction of R lipopolysaccharide. Eur. J. Biochem. 9:245-249[Medline].
17. Galdiero, F., G. Cipollaro de l'Ero, N. Benedetto, M. Galdiero, and M. A. Tufano. 1993. Release of cytokines induced by Salmonella typhimurium porins. Infect. Immun. 61:155-159[Abstract/Free Full Text].
18. Galdiero, F., M. A. Tufano, M. Galdiero, S. Masiello, and M. Di Rosa. 1990. Inflammatory effect of Salmonella typhimurium porins. Infect. Immun. 58:3183-3188[Abstract/Free Full Text].
19. Galdiero, F., M. A. Tufano, L. Sommese, A. Folgore, and F. Tedesco. 1984. Activation of the complement system by porins extracted from Salmonella typhimurium. Infect. Immun. 46:559-563[Abstract/Free Full Text].
20. Galdiero, M., G. Cipollaro de l'Ero, G. Donnarumma, A. Marcatili, and F. Galdiero. 1995. Interleukin-1 and interleukin-6 gene expression in human monocytes stimulated with Salmonella typhimurium porins. Immunology 86:612-619[Medline].
21. Galdiero, M., L. De Martino, A. Marcatili, I. Nuzzo, M. Vitiello, and G. Cipollaro de l'Ero. 1998. Th1 and Th2 cell involvement in immune response to Salmonella typhimurium porins. Immunology 94:5-13[CrossRef][Medline].
22. Galdiero, M., A. Folgore, M. Molitierno, and R. Greco. 1999. Porins and lipopolysaccharide (LPS) from Salmonella typhimurium induce leukocyte transmigration through human endothelial cells in vitro. Clin. Exp. Immunol. 116:453-461[CrossRef][Medline].
23. Groeneveld, K., L. van Alphen, C. Voorter, P. P. Eijk, H. M. Jansen, and H. C. Zanen. 1989. Antigenic drift of Haemophilus influenzae in patients with chronic obstructive pulmonary disease. Infect. Immun. 57:3038-3044[Abstract/Free Full Text].
24. Hansen, E. J., C. Hasemann, A. Clausell, J. D. Capra, K. Orth, C. R. Moomaw, C. A. Slaughter, J. L. Latimer, and E. E. Miller. 1989. Primary structure of the porin of Haemophilus influenzae type b determined by nucleotide sequence analysis. Infect. Immun. 57:1100-1107[Abstract/Free Full Text].
25. Hopkins, W. J., A. Gendron-Fitzpatrick, D. O. McCarthy, J. E. Haine, and D. T. Uehling. 1996. LPS-responder and nonresponder C3H mouse strains are equally susceptible to an induced Escherichia coli urinary tract infection. Infect. Immun. 64:1369-1374[Abstract].
26. Iovane, G., P. Pagnini, M. Galdiero, G. Cipollaro de l'Ero, M. Vitiello, M. D'Isanto, and A. Marcatili. 1998. Role of Pasteurella multocida porin on cytokine expression and release by murine splenocytes. Vet. Immunol. Immunopathol. 66:391-404[CrossRef][Medline].
27. Kamiya, H., S. Uehara, T. Kato, K. Shiraki, T. Togashi, T. Morishima, O. Satoh, and S. M. Standaert. 1998. Childhood bacterial meningitis in Japan. Pediatr. Infect. Dis. J. 17:S183-S185[CrossRef][Medline].
28. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 277:680-685.
29. Leist, T. P., K. Frei, S. Kam-Hansen, R. M. Zinkernagel, and A. Fontana. 1988. Tumor necrosis factor-alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and patients. J. Exp. Med. 167:1743-1748[Abstract/Free Full Text].
30. Levine, O. S., and B. Schwartz. 1998. The rationale for population-based surveillance for Haemophilus influenzae type b meningitis. Pediatr. Infect. Dis. J. 17:S195-S198[CrossRef][Medline].
31. Loeb, M. R., and D. H. Smith. 1980. Outer membrane protein composition in disease isolates of Haemophilus influenzae: pathogenic and epidemiological implications. Infect. Immun. 30:709-717[Abstract/Free Full Text].
32. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1985. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:265-275.
33. McCracken, G. H., Jr., M. M. Mustafa, O. Ramilo, K. D. Olsen, and R. C. Risser. 1989. Cerebrospinal fluid interleukin-1beta and tumor necrosis factor concentrations and outcome from neonatal gram-negative enteric bacillary meningitis. Pediatr. Infect. Dis. J. 8:155-159[Medline].
34. Morrison, D. C., and D. M. Jacobs. 1976. Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides. Immunochemistry 13:813-818[CrossRef][Medline].
35. Munson, R. S., Jr., J. L. Shenep, and S. J. Barenkamp. 1983. Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates. J. Clin. Investig. 72:677-684.
36. Munson, R. S., Jr., and R. W. Tolan, Jr. 1989. Molecular cloning, expression, and primary sequence of outer membrane protein P2 gene of Haemophilus influenzae type b. Infect. Immun. 57:88-94[Abstract/Free Full Text].
37. Murphy, T. F., K. C. Dudas, J. M. Mylotte, and M. A. Apicella. 1983. A subtyping system for nontypable Haemophilus influenzae based on outer membrane proteins. J. Infect. Dis. 147:838-846[Medline].
38. Mustafa, M. M., O. Ramilo, K. D. Olsen, P. S. Franklin, E. J. Hansen, B. Beutler, and G. H. McCracken, Jr. 1989. Tumor necrosis factor in mediating experimental Haemophilus influenzae type b meningitis. J. Clin. Investig. 84:1253-1259.
39. Mustafa, M. M., O. Ramilo, G. A. Syrogiannopoulos, K. D. Olsen, G. H. McCracken, Jr., and E. J. Hansen. 1989. Induction of meningeal inflammation by outer membrane vesicles of Haemophilus influenzae type b. J. Infect. Dis. 159:917-922[Medline].
40. Nikaido, H., and E. Y. Rosenberg. 1983. Porin channels in Escherichia coli: studies with liposomes reconstituted from purified proteins. J. Bacteriol. 153:241-252[Abstract/Free Full Text].
41. Nurminen, M. 1985. Isolation of porin trimers. Enterobacterial surface antigen: methods for molecular characterization. FEMS Symp. 25:294.
42. Paxinos, G., and C. Watson. 1986. The rat brain in the stereotaxic coordinates, 2nd ed. Academic Press, Sydney, Australia.
43. Ramilo, O., X. Sàez-Llorens, J. Mertsola, H. Jafari, K. D. Olsen, E. J. Hansen, M. Yoshinaga, S. Ohkawara, H. Nariuchi, and G. H. McCracken, Jr. 1990. Tumor necrosis factor alpha /cachectin and interleukin 1beta initiate meningeal inflammation. J. Exp. Med. 172:497-507[Abstract/Free Full Text].
44. Ransohoff, R. M. 1997. Chemokines in neurological disease models: correlation between chemokine expression patterns and inflammatory pathology. J. Leukoc. Biol. 62:645-652[Abstract].
45. Saukkonen, K., S. Sande, C. Cioffe, S. Wolpe, B. Sherry, A. Cerami, and E. Tuomanen. 1990. The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis. J. Exp. Med. 171:439-448[Abstract/Free Full Text].
46. Shenep, J. L., P. M. Flynn, E. F. Barrett, G. L. Stidham, and D. F. Westenkirchner. 1988. Serial quantitation of endotoxemia and bacteremia during therapy for gram negative bacterial sepsis. J. Infect. Dis. 157:565-568[Medline].
47. Syrogiannopoulos, G. A., E. J. Hansen, A. L. Erwin, R. S. Munnford, J. Rutledge, J. S. Reisch, and G. H. McCracken, Jr. 1988. Haemophilus influenzae type b lipooligosaccharide induces meningeal inflammation. J. Infect. Dis. 157:237-244[Medline].
48. Tekamp-Olson, P., C. Gallegos, D. Bauer, J. McClain, R. Sherry, M. Fabre, S. van Deventer, and A. Cerami. 1990. Cloning and characterization of cDNA for murine macrophage inflammatory protein and its human homologues. J. Exp. Med. 172:911-919[Abstract/Free Full Text].
49. Thye Yin, E., C. Galanos, S. Kinsky, R. A. Bradshow, S. Wessler, O. Luderitz, and M. F. Sarmiento. 1972. Picogram sensitive assay for endotoxin: gelatin of Limulus polyphemus blood cell lysate induced by purified lipopolysaccharide and lipid A from Gram-negative bacteria. Biochim. Biophys. Acta 261:245-249[Medline].
50. Tsai, C. M., and C. E. Frasch. 1982. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal. Biochem. 119:115-119[CrossRef][Medline].
51. Waage, A., A. Halstensen, R. Shalaby, P. Brandtzaeg, P. Kierulf, and T. Espevik. 1989. Local production of tumor necrosis factor alpha , interleukin 1, and interleukin 6 in meningococcal meningitis. J. Exp. Med. 170:1859-1867[Abstract/Free Full Text].
52. Woolpe, S. D., B. Sherry, D. Jurres, G. Davatelis, R. W. Yurt, and A. Cerami. 1989. Identification and characterization of macrophage inflammatory protein 2. Proc. Natl. Acad. Sci. USA 86:612-617[Abstract/Free Full Text].
53. Zhang, H., D. W. Nielsen, J. W. Peterson, and G. R. Klimpel. 1998. Lipoprotein release by bacteria: potential factor in bacterial pathogenesis. Infect. Immun. 66:5196-5201[Abstract/Free Full Text].


Infection and Immunity, January 2001, p. 221-227, Vol. 69, No. 1
0019-9567/01/$04.00+0   DOI: 10.1128/IAI.69.1.221-227.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Berenson, C. S., Murphy, T. F., Wrona, C. T., Sethi, S. (2005). Outer Membrane Protein P6 of Nontypeable Haemophilus influenzae Is a Potent and Selective Inducer of Human Macrophage Proinflammatory Cytokines. Infect. Immun. 73: 2728-2735 [Abstract] [Full Text]  
  • Prather, D. T., Bains, M., Hancock, R. E. W., Filiatrault, M. J., Campagnari, A. A. (2004). Differential Expression of Porins OmpP2A and OmpP2B of Haemophilus ducreyi. Infect. Immun. 72: 6271-6278 [Abstract] [Full Text]  
  • Galdiero, M., Galdiero, M., Finamore, E., Rossano, F., Gambuzza, M., Catania, M. R., Teti, G., Midiri, A., Mancuso, G. (2004). Haemophilus influenzae Porin Induces Toll-Like Receptor 2-Mediated Cytokine Production in Human Monocytes and Mouse Macrophages. Infect. Immun. 72: 1204-1209 [Abstract] [Full Text]  
  • Galdiero, S., Capasso, D., Vitiello, M., D'Isanto, M., Pedone, C., Galdiero, M. (2003). Role of Surface-Exposed Loops of Haemophilus influenzae Protein P2 in the Mitogen-Activated Protein Kinase Cascade. Infect. Immun. 71: 2798-2809 [Abstract] [Full Text]  
  • Galdiero, M., Vitiello, M., Sanzari, E., D'Isanto, M., Tortora, A., Longanella, A., Galdiero, S. (2002). Porins from Salmonella enterica Serovar Typhimurium Activate the Transcription Factors Activating Protein 1 and NF-{kappa}B through the Raf-1-Mitogen-Activated Protein Kinase Cascade. Infect. Immun. 70: 558-568 [Abstract] [Full Text]  
  • Galdiero, M., D'Isanto, M., Vitiello, M., Finamore, E., Peluso, L., Galdiero, M. (2001). Porins from Salmonella enterica serovar Typhimurium induce TNF-{alpha}, IL-6 and IL-8 release by CD14-independent and CD11a/CD18-dependent mechanisms. Microbiology 147: 2697-2704 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Galdiero, M.
Right arrow Articles by Tortora, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galdiero, M.
Right arrow Articles by Tortora, A.